one-color microarray hybridization protocol, v6.5 (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
one-color microarray hybridization protocol, v6.5
One Color Microarray Hybridization Protocol, V6.5, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+hybridization+protocols/pm24704562-89-23-24
Average 90 stars, based on 1 article reviews
One Color Microarray Hybridization Protocol, V6.5, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+hybridization+protocols/pm24704562-89-23-24
Average 90 stars, based on 1 article reviews
one-color microarray hybridization protocol, v6.5 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Hybridization:Article Title: MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway Article Snippet: .. The labelling and hybridization were performed according to protocols in the Article Title: Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers Article Snippet: .. After hybridization to microarrays for 40 hours at 65° C. in a rotating oven, the microarrays were washed and dried according to the manufacturer's protocols, and then imaged with Article Title: Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers Article Snippet: .. After hybridization to microarrays for 40 hours at 65° C. in a rotating oven, the microarrays were washed and dried according to the manufacturer's protocols, and then imaged with Article Title: Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis Article Snippet: MicroRNA microarray and data analysis To determine the diverse miRNA expression in platelets between LPR and HPR patients, we performed miRNA expression profiles of LDP samples from four LPR and four HPR patients using Agilent human miRNA microarray (version 19.0) system (Agilent technologies, Santa Clara, CA, USA). .. The miRNA molecular labeling, array hybridization and data scanning were performed at Biochip Company (Shanghai, China), according to the protocols of the Article Title: Meta-microRNAs as potential noninvasive markers for early diagnosis of Alzheimer’s disease Article Snippet: .. The labeling and hybridization were performed according to the protocols in the Article Title: Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma Article Snippet: .. Hybridization and labeling were performed according to the protocols in the Microarray:Article Title: MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway Article Snippet: .. The labelling and hybridization were performed according to protocols in the Article Title: Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers Article Snippet: .. After hybridization to microarrays for 40 hours at 65° C. in a rotating oven, the microarrays were washed and dried according to the manufacturer's protocols, and then imaged with Article Title: Targeting abnormal DNA repair in therapy-resistant breast and pancreatic cancers Article Snippet: .. After hybridization to microarrays for 40 hours at 65° C. in a rotating oven, the microarrays were washed and dried according to the manufacturer's protocols, and then imaged with Article Title: Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis Article Snippet: MicroRNA microarray and data analysis To determine the diverse miRNA expression in platelets between LPR and HPR patients, we performed miRNA expression profiles of LDP samples from four LPR and four HPR patients using Agilent human miRNA microarray (version 19.0) system (Agilent technologies, Santa Clara, CA, USA). .. The miRNA molecular labeling, array hybridization and data scanning were performed at Biochip Company (Shanghai, China), according to the protocols of the Article Title: Meta-microRNAs as potential noninvasive markers for early diagnosis of Alzheimer’s disease Article Snippet: .. The labeling and hybridization were performed according to the protocols in the Article Title: Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma Article Snippet: .. Hybridization and labeling were performed according to the protocols in the In Situ Hybridization:Article Title: The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a−/−) mice, a model of inflammatory bowel diseases Article Snippet: .. Labelled cRNA were hybridised using an In Situ Hybridization Plus Kit (Agilent Technologies), following the manufacturer’s protocols, using 750 ng of experimental and reference cRNA onto other:Article Title: Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase Article Snippet: After hybridization the Labeling:Article Title: Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis Article Snippet: MicroRNA microarray and data analysis To determine the diverse miRNA expression in platelets between LPR and HPR patients, we performed miRNA expression profiles of LDP samples from four LPR and four HPR patients using Agilent human miRNA microarray (version 19.0) system (Agilent technologies, Santa Clara, CA, USA). .. The miRNA molecular labeling, array hybridization and data scanning were performed at Biochip Company (Shanghai, China), according to the protocols of the Article Title: Meta-microRNAs as potential noninvasive markers for early diagnosis of Alzheimer’s disease Article Snippet: .. The labeling and hybridization were performed according to the protocols in the Article Title: Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma Article Snippet: .. Hybridization and labeling were performed according to the protocols in the |
